LeonaBio, Inc. Conversion of Stock, Amount Converted
LeonaBio, Inc. (LONA) reported Conversion of Stock, Amount Converted of $92.54 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2022-03-28
- LeonaBio, Inc. conversion of stock, amount converted for the quarter ending 2020-12-31 was $0.00.
- LeonaBio, Inc. conversion of stock, amount converted for fiscal 2020 was $92.54M.
| Period end | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $92.54M 10-K · filed 2022-03-28 | |
| 2020-09-30 | $92.54M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |